Accessibility Menu
Life Stem Genetics logo

Life Stem Genetics(OTC) LIFS

Market Cap$24.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-100%
5 Year+0%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Life Stem Genetics last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-31
Life Stem Genetics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-23
1 month+0%USD 0.002026-06-29
3 month+0%USD 0.002026-04-23
Year to date-50%USD 0.002025-12-31
1 year+0%USD 0.002025-06-24
3 year-97.14%USD 0.002023-07-31
5 year+0%USD 0.002021-07-28
Since inception-99.99%USD 1.042013-10-22

Life Stem Genetics Financials at a Glance

Market Cap

$24.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.35K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-103.25 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

LIFS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Life Stem Genetics

Life Stem Genetics Inc. is a biotechnology company focused on developing a global network of clinics specializing in stem cell therapy. The company offers a range of services, including stem cell banking, nutraceuticals, and various therapeutic treatments for degenerative conditions and anti-aging.

Products and Services
  • Stem cell banking services for future medical use
  • Nutraceuticals and medical supplements for health enhancement
  • Adistem treatments for orthopedic and neurological conditions
Growth Outlook
  • Strategic collaborations enhance service offerings and market reach
  • Increasing demand for stem cell therapies in healthcare
  • Focus on expanding clinic network to capture new markets
Financial Highlights
  • Recent quarterly net income of -$300, indicating ongoing investment in growth
  • Trailing twelve months show consistent operating expenses, reflecting stability
  • Stock price range between $0.0001 and $0.0003, suggesting potential for growth
Life Stem Genetics Inc. operates in a promising sector with a focus on innovative therapies. The company's commitment to expanding its clinic network and enhancing its service offerings positions it well for future growth. Despite recent financial challenges, the ongoing investment in research and development and strategic partnerships may lead to significant advancements in the stem cell therapy market. The biotechnology industry continues to evolve, and Life Stem Genetics Inc. aims to be at the forefront of this transformation.
AI Generated • Jul 31, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

1

CEO

Xin Shi

Website

www.lifestemgenetics.com

Headquarters

East Stroudsburg, PA 18301, US

LIFS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

245.84M

Volume

1.00K

Avg. Volume

576.841

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$10.35K

EBITDA

-$10.35K

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Life Stem Genetics Performance Analysis

Life Stem Genetics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 0N/A
20232023-06-30USD 0N/A
20242024-06-30USD 0N/A
20252025-06-30USD 0N/A
Life Stem Genetics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30N/A
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Life Stem Genetics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD 0.00N/A
20232023-06-30USD -0.00N/A
20242024-06-30USD -0.00-77.8%
20252025-06-30USD 0.00N/A
Life Stem Genetics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30100.0%
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$24.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$300.00

+72.3%

EBITDA

-$300.00

+71.4%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLUNHEALTHeUNIVERSE, Inc.
$0.00+0.00%
TRVNTrevena, Inc.
$0.01+0.00%
CGHCCapital Group Holdings, Inc.
$0.00+0.00%
INFIQInfinity Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
FCUVFocus Universal
$11.60+5.17%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$23.67-0.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.62+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.73-0.02%

Questions About LIFS

What is the current price of Life Stem Genetics?

Life Stem Genetics is trading at $0.00 per share.

What is the 52-week range for Life Stem Genetics?

Over the past 52 weeks, Life Stem Genetics has traded between $0.00 and $0.00.

How much debt does Life Stem Genetics have?

As of the most recent reporting period, Life Stem Genetics reported total debt of $0.00.

How much cash does Life Stem Genetics have on hand?

Life Stem Genetics reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Life Stem Genetics’s dividend yield?

Life Stem Genetics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services